RxDoctor Payments Data

Katherine Myerholtz, NP

Family · Fremont, OHNPI 1578901062

Payments from drug & device makers

$1,021in general payments, 2019–2025

Across 62 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$287
  • AstraZeneca$161
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$82
  • Merck$77
  • GSK$76
  • Boehringer Ingelheim$54
  • plus $284 from 13 others

What the payments were for

  • Food & beverage$1,021100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,021 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$405
Medicare patients
11
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$63,543
JanuviaSitagliptin Phosphate27$40,360
JardianceEmpagliflozin30$35,860
TrulicityDulaglutide13$25,562
FarxigaDapagliflozin Propanediol16$22,541
EliquisApixaban24$18,280
Breo ElliptaFluticasone/Vilanterol15$9,132
SymbicortBudesonide/Formoterol Fumarate14$4,578
Albuterol Sulfate HfaAlbuterol Sulfate141$3,255
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,076
Diclofenac Sodium85$1,812
Ezetimibe17$1,737
Omeprazole113$1,456
Montelukast Sodium121$1,423
Atorvastatin Calcium200$1,417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$63,54348 claims
MerckJanuvia$77$40,36027 claims
Boehringer IngelheimJardiance$54$35,86030 claims
AstraZenecaFarxiga, Symbicort$161$27,11930 claims
PfizerEliquis$13$18,28024 claims
GSKBreo Ellipta$76$9,13215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,812 family providers in Ohio.

Other family in Fremont

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →